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ABSTRACT 
The aim of the present study was to prepare bi-layer tablet of Metronidazole and Dicyclomine Hydrochloride for the effective 
treatment of Irritable Bowel Disease. Metronidazole and Dicyclomine Hydrochloride were formulated as immediate and sustained 
release layer respectively. The rational for formulation of bi-layer tablet of these two combinations was Metronidazole (immediate 
release) is strong antibiotic usually applied for antidiarrheal to treat inflammation of the large intestine and Dicyclomine 
Hydrochloride (Sustained release) is anticholinergic drug primarily used for irritable bowel disease. Bilayer tablet was suitable for 
maximize the efficacy of drugs in irritable bowel disease. 
 
Cite this article as: Sharma A, Sharma PK, Darwhekar G, Formulation and evaluation of bilayer tablet of metronidazole and 
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INTRODUCTION: 
In the last two decades, Irritable Bowel Syndrome (IBS) 
has gained considerable attention in the health-care field 
due to its increasingly high prevalence, sometimes 
debilitating effects and diverse symptom representation
1
. 
Bi-layer tablet is suitable for sequential release of two 
drugs in combination, separate two incompatible 
substances, and also for sustained release tablet in which 
one layer is immediate release as initial dose and second 
layer is maintenance dose
2
.
 
Metronidazole 2-(2-methyl-
5-nitroimidazol-1-yl)ethanol is a potent antibiotic 
usually applied for treatment of anaerobic infections and 
mixed infections, surgical prophylaxis requiring 
anaerobic coverage, Clostridium difficile-associated 
diarrhea and colitis diarrhea. The drug has potent 
activity and Well absorbed (at least 80%) with peak 
plasma concentrations achieved in 1-3 hours following 
oral administration of therapeutic doses of immediate 
release formulation. Dicyclomine Hydrochloride 2-
(diethylamino) ethyl 1-cyclohexyl cyclohexane-1-
carboxylate; hydrochlorideis a muscarinic antagonist 
used as an antispasmodic and in urinary incontinence. It 
antagonizes muscarinic receptors on smooth muscle in 
the gastrointestinal (GI) tract, thereby preventing the 
actions of acetylcholine and reducing GI smooth muscle 
spasms. 
MATERIAL AND METHODS:  
Materials 
Dicyclomine Hydrochloride was a gift sample obtained 
from Shreepati Pharma, Indore, Metronidazole was a gift 
sample obtained from Modern Laboratories, Indore, 
Sodium Starch Glycolate, Poly vinyl Pyrollidone (PVP 
K-30), Magnesium stearate, Talc, Isopropyl alcohol 
were procured from Kasliwal Brothers Indore. All 
chemicals were used of analytical grade. 
Methods 
UV Analysis 
Calibration curve of Metronidazole  
The calibration curve of Metronidazole was prepared in 
distilled water and 1.8 pH phosphate buffer by using 
Shimadzu 1800 UV visible spectrophotometer. 
Accurately weighed 50mg of Metronidazole was 
transferred into a 50ml volumetric flask and the volume 
was made up with methanol to obtain a 1000µg/ml stock 
solution of Metronidazole. From the stock solution 1ml 
was taken and transferred into a 10ml volumetric flask 
and rest of the volume was made up with methanol to 
obtain a 100µg/ml of solution from which 1 to 10µg/ml 
dilutions were prepared
3
. 
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Calibration curve of Dicyclomine Hydrochloride 
        
The calibration curve of Dicyclomine Hydrochloride 
were prepared in distilled water and 7.2 pH phosphate 
buffer by using Shimadzu 1800 UV visible 
spectrophotometer. Same procedure as mentioned above 
is utilized in phospate buffer 7.2 respectively. 
Solubility studies 
The solubility of both drugs in various medium was 
determined by shake flask method. In this method 2ml 
of each solvent was taken into a vial and an excess 
amount of drug was added. The vials were sealed 
properly and stirred for 10min. They were then kept on 
orbital flask shaker at 37°C for 24h. After solubilization 
of drug, an extra amount of drug was added to the vials 
containing drug-solvent mixture. The process was 
repeated until saturation solubility of drug, indicated by 
presence of undissolved drug. The mixtures were then 
kept at room temperature for 24 h. and centrifuged using 
Remi12C micro-centrifuge at 3000RPM for 15min. The 
supernatant were separated and diluted with respective 
solvents. The drug concentration was analyzed 
spectrophotometrically at 212 and 274 nm using UV-
visible spectrophotometer (Shimadzu-1800)
 3
. 
Preparation of Metronidazole Immediate release 
layer by Direct Compression 
Weigh all Ingredients as per the quantities shown in 
table no. 1. Pass all the ingredients through sieve #80 
and collect individuals in polybags. Mix measured 
quantity of Metronidazole, SSG and PVP-K30 for 15 
minutes in a polybag. Magnesium stearate and talc was 
added to it and blend for 5 min in pastle mortar. 
Compress final blend using B-Tooling, multiple rotatory 
compression machine using 8 mm round shaped 
punches and corresponding dies. 
 
 
Table 1: Formula for immediate release layer 
S. 
N. 
Ingredients Quantity 
Per 10 Tablets (in mg) 
1. Metronidazole 2500 
2. Sodium starch glycolate 300 
3. PVP K-30 150 
4. Magnesium Stearate 50 
5. Talc 50 
 
Preparation of Dicyclomine Hydrochloride Sustained 
release layer by Wet Granulation 
Weigh all Ingredients as per the quantities defined in 
tablet no. 2. Pass all the ingredients through sieve no 
#80 and collect in separate polybags. Prepare binder 
solution by dissolving PVP-K30 in Isopropyl alcohol. 
Mix all material expect lubricant for 15 min. Add binder 
solution to the above step and mix until uniform dough 
mass granules are formed. Pass all granules through #12 
no. sieve. Dry all the granules at 50-55ᴼC temperature. 
Add Magnesium stearate and Talc and blend it for 5 
Minute. Compress final blend using B-tooling, multiple 
rotatory compression machine uses 8 mm round shape 
punches and corresponding dies. 
Selection of polymers and suitable experimental 
design 
A central composite design for two factor three level 
was selected to optimize the variable response. The two 
factors, viz. Polymer X1Eudragit RSPO and Polymer X2 
PVP-K30 of each polymer blend, were required by the 
experimental design and the factor level were suitably 
coded. The amount of Magnesium stearate was kept 
constant, while Isopropyl alcohol was taken in a 
sufficient quantity to maintain a constant tablet mass of 
200mg. time taken to release 50% of drug were taken as 
the variable response 
4
. 
 
Table 2: Formulation optimization data 
S.No. Ingredients F1 F2 F3 F4 F5 F6 F7 F8 F9 
1. Dicyclomine Hydrochloride 200 200 200 200 200 200 200 200 200 
2. Eudragit RSPO 400 400 400 500 500 500 600 600 600 
3. Microcrystalline cellulose 800 800 800 800 800 800 800 800 800 
4. PVP-K30 80 100 120 80 100 120 80 100 120 
5. Magnesium Stearate 50 50 50 50 50 50 50 50 50 
6. Talc 50 50 50 50 50 50 50 50 50 
7. Isopropyl alcohol QS QS QS QS QS QS QS QS QS 
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Evaluation of Granules 
To find out physiochemical properties and release 
characteristics of the granular blend, all formulations are 
subjected to pre-formulation studies like bulk density, 
tapped density, Angle of repose, compressibility index 
and Hausner’s ratio. 
Preparation of Bilayer tablets of Metronidazole and 
Dicyclomine Hydrochloride 
Optimized batch of Metronidazole and Dicyclomine 
Hydrochloride were selected for formulation of bilayer 
tablet. As previously reported procedure for granules of 
immediate and sustained release layer were blended 
separately. One by one both layer was filled in rotatory 
compression machine and compressed.  
Evaluation of compressed tablets 
The tablets prepared were evaluated for weight 
variation, disintegration test, dissolution test, thickness, 
hardness of individual dose and friability. 
Weight variation  
The weight variation was performed by weighing 20 
tablets individually, then individual weight of tablet is 
compared with average weight of 20 tablets. 
Hardness 
The hardness of each batch of tablet was checked by 
using Monsanto hardness tester. The hardness was 
measured in terms of kg/cm2.  
Friability  
The friability was determined by first weighing 10 
tablets before placing in friability tester (Roche 
friabilator), which was rotated for 4 min at 25 rpm. After 
dusting, the remaining weight of tablet was determined. 
Thickness 
The thickness of tablet was determined by vernier 
caliper. 
Disintegration 
The test was performed by introducing one tablet in each 
tube and adds a disc to each tube. Suspend the assembly 
in the beaker containing purified water and operate the 
apparatus until the tablet completely disintegrates. 
In Vitro Dissolution test 
The in-vitro dissolution studies were carried out using 
USP apparatus type II at 50 rpm. The dissolution 
medium (900 ml) consisted of simulated gastric fluid 
(pH 1.2 HCL buffer) was used for the first 2 hour and 
then replaced with phosphate buffer (pH 7.2) for 3 to 8 
hours (900 ml), maintained at 37±0.5ºC. The drug 
release at different time interval was measured by UV-
visible spectrophotometer at 212 nm and 274 nm. The 
release studies were conducted on six tablets in each 
batch and the mean values were plotted versus time 
4
. 
RESULT AND DISCUSSION: 
Metronidazole and Dicyclomine Hydrochloride Bilayer 
tablet was formulated. Total nine batches were prepared 
for sustained release layer. All the formulations were 
subjected to evaluation, Tablet weight of sustained 
release layer varied from 155 to 189 mg, and thickness 3 
to 4.1 mm. All the tablets exhibited friability values 
between 0.22 to 0.3, all immediate release layer 
disintegrated in less than 1 minute.  
CONCLUSION: 
The present study was carried out to prove that bi-layer 
tablet of Metronidazole and Dicyclomine Hydrochloride 
as Immediate and Sustained release layer can be 
formulated. The concept explains the application of 
IR/SR from single dosage form which results in cost 
effectiveness and reduces the problems of irritable bowel 
disease.  
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